Surgical staging of cancer: Impact on prognosis and potential for bias in clinical trials Maurie Markman Editor’s Commentary Pages: 437 - 438
Intraperitoneal chemotherapy for ovarian cancer Gregory FribergGini Fleming OriginalPaper Pages: 447 - 453
Consolidation/maintenance chemotherapy for ovarian cancer Maurie Markman OriginalPaper Pages: 454 - 458
Biologic directed therapies in gynecologic oncology John H. FarleyMichael J. Birrer OriginalPaper Pages: 459 - 467
Current research directions for locally advanced cervix cancer Harry J. Long III OriginalPaper Pages: 468 - 472
The role of interval debulking surgery in ovarian cancer Maria E. L. van der BurgIgnace Vergote OriginalPaper Pages: 473 - 481
Surgery for elderly patients with ovarian cancer Martin G. A. BäuerleRolf KreienbergTanja Volm OriginalPaper Pages: 482 - 485
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia Soheil MeshinchiFranklin O. SmithRobert J. Arceci OriginalPaper Pages: 489 - 497
The development of VAC chemotherapy in Rhabdomyosarcoma: What does one do for an encore? Frederick B. Ruymann OriginalPaper Pages: 505 - 509
Juvenile myelomonocytic leukemia Charlotte Marie NiemeyerChristian Kratz OriginalPaper Pages: 510 - 515